ObsEva
ClosedPublic · Geneva, Switzerland · Founded 2012 · $111.0M raised
- Headquarters
- Geneva
- Employees
- 11–50
- Founded
- 2012
- Business Model
- B2B
- Total Funding
- $111.0M
- Last Round
- $20.0M Venture RoundSep 2020
- Rounds
- 3
- Type
- Public
About
Founded in 2012 and headquartered in Geneva, Switzerland, ObsEva SA (formerly Nasdaq: OBSV) was a biopharmaceutical company focused on developing and commercializing novel therapies for conditions in women's reproductive health and pregnancy. The company's pipeline included linzagolix (GnRH receptor antagonist for uterine fibroids and endometriosis) and ebopiprant (for preterm labor). ObsEva completed an IPO in 2018. Due to financial difficulties, the company undertook a strategic reorganization in 2023 and ultimately wound down operations and laid off all employees in February 2024.
Summary
ObsEva is a Biotech company based in Geneva, Switzerland, founded in 2012. It has raised $111.0M in total across 3 rounds, most recently a $20.0M Venture Round round in Sep 2020.
Funding History
Sep 2020
Sign up to see all 4 rounds
Series A through Venture Round — per-round amounts, valuations, and who invested in each round.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/obseva"><img src="https://indexed.vc/api/badge/company/obseva" alt="ObsEva on Indexed.vc" width="260" height="76" /></a>